JPRN-UMIN000023248已完成未知
Investigation on the usefulness of liquid biopsy for tumor-derived circulating DNA in patients with EGFR-mutant NSCLC during and after treatment with EGFR-TKIs - JP-CLEAR (Japanese Prospective evaluation of tumor-derived Circulating DNA Liquid biopsy in patients with EGFR-mutant NSCLC during and after Acquired Resistance to EGFR-TKI treatment)
PHRF0 个研究点目标入组 122 人开始时间: 2016年7月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 122
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Prior treatment with EGFR-TKI 2)HBsAg or HCV-RNA positive Patients 3)HIV positive Patients
研究者
相似试验
进行中（未招募）
1 期
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code: 10025055Term: Lung cancer non-small cell stage IV Class: 10029104CTIS2024-511317-38-00Fundacion GECP33
进行中（未招募）
1 期
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864EUCTR2019-002369-36-ESFundación GECP30
招募中
不适用
Exploratory research of liquid biopsy for patients with cancercancerJPRN-UMIN000033269Cancer Precision Medicine Center Cancer Institute,800
招募中
Unknown
Validation process of liquid biopsy for solid tumorsCTRI/2023/03/050258Cancer Research and Statistic Foundation CRSF
尚未招募
Unknown
Exploratory analysis of liquid biopsy for the predictive factors associated with outcome of PD-1 Pathway Blockade in Multicenter Studynon-small cell lung cancerJPRN-jRCT1032220559Ohe Yuichiro100